International Journal of
Reproductive Biomedicine
Sat, Apr 20, 2024
[Archive]
Volume 9, Issue 2 (7-2011)
IJRM 2011, 9(2): 119-124 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Moini A, Zafarani F, Eslami B, Sadeghi M, Kamyabi Z, Jahangiri N. Comparing intramuscular progesterone, vaginal progesterone and 17 a-hydroxyprogestrone caproate in IVF and ICSI cycle. IJRM 2011; 9 (2) :119-124
URL: http://ijrm.ir/article-1-213-en.html
URL: http://ijrm.ir/article-1-213-en.html
Ashraf Moini * 
1, Fatemeh Zafarani2 , Bita Eslami3 , Maria Sadeghi2 , Zahra Kamyabi2 , Nadia Jahangiri2
1, Fatemeh Zafarani2 , Bita Eslami3 , Maria Sadeghi2 , Zahra Kamyabi2 , Nadia Jahangiri2
1- Department of Endocrinology and Female Infertility, Royan Institute of Reproductive Biomedicine, ACECR, Tehran, Iran , a_moini@royaninstitute.org
2- Department of Endocrinology and Female Infertility, Royan Institute of Reproductive Biomedicine, ACECR, Tehran, Iran
3- Department of Obstetrics and Gynecology, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Endocrinology and Female Infertility, Royan Institute of Reproductive Biomedicine, ACECR, Tehran, Iran
3- Department of Obstetrics and Gynecology, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran
Abstract: (10111 Views)
Background: Supplementation of luteal phase with progesterone is prescribed for women undergoing routine IVF treatment.
Objective: The objective of this study was to compare the efficacy of three types of progesterone on biochemical, clinical and ongoing pregnancy rates and abortion and live birth rates.
Materials and Methods: A prospective randomized study was performed at Royan Institute between March 2008 and March 2009 in women under 40 years old, who use GnRH analog down-regulation. One hundred eighty six patients in three groups were received progesterone in oil (100 mg, IM daily), intravaginal progesterone (400 mg, twice daily) and 17-a hydroxyprogestrone caproate (375mg, every three days), respectively.
Results: Final statistical analysis after withdrawal of some patients was performed in 50, 50 and 53 patients in group 1, 2 and 3 respectively. No differences between the groups were found in baseline characteristics. No statistical significance different was discovered for biochemical, clinical and ongoing pregnancies. Although the abortion rate was statistically higher in group 1 (p=0.025) the live birth rate was not statistically significant between the three groups.
Conclusion: The effects of three types of progesterone were similar on pregnancies rate. We suggest the use of intravaginal progesterone during the luteal phase in patients undergoing an IVF-ET program because of the low numbers of abortions, and high ongoing pregnancy rates.
Objective: The objective of this study was to compare the efficacy of three types of progesterone on biochemical, clinical and ongoing pregnancy rates and abortion and live birth rates.
Materials and Methods: A prospective randomized study was performed at Royan Institute between March 2008 and March 2009 in women under 40 years old, who use GnRH analog down-regulation. One hundred eighty six patients in three groups were received progesterone in oil (100 mg, IM daily), intravaginal progesterone (400 mg, twice daily) and 17-a hydroxyprogestrone caproate (375mg, every three days), respectively.
Results: Final statistical analysis after withdrawal of some patients was performed in 50, 50 and 53 patients in group 1, 2 and 3 respectively. No differences between the groups were found in baseline characteristics. No statistical significance different was discovered for biochemical, clinical and ongoing pregnancies. Although the abortion rate was statistically higher in group 1 (p=0.025) the live birth rate was not statistically significant between the three groups.
Conclusion: The effects of three types of progesterone were similar on pregnancies rate. We suggest the use of intravaginal progesterone during the luteal phase in patients undergoing an IVF-ET program because of the low numbers of abortions, and high ongoing pregnancy rates.
Type of Study: Original Article |
References
1. Herman A, Raziel A, Strassburger D, Soffer Y, Bukovsky I, Ron-El R. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone. Hum Reprod 1996; 11: 1552-1557. [DOI:10.1093/oxfordjournals.humrep.a019436]
2. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 1994; 61: 1068-1076. [DOI:10.1016/S0015-0282(16)56758-2]
3. Propst AM, Hill JA, Ginsburg ES, Hurwitz S, Politch J, Yanushpolsky EH. A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. Fertil Steril 2001; 76: 1144-1149. [DOI:10.1016/S0015-0282(01)02872-2]
4. Damario MA, Goudas VT, Session DR, Hammitt DG, Dumesic DA. Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficacy after in vitro fertilization-embryo transfer. Fertil Steril 1999; 72: 830-836. [DOI:10.1016/S0015-0282(99)00364-7]
5. Chantilis SJ, Zeitoun KM, Patel SI, Johns DA, Madziar VA, McIntire DD. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertil Steril 1999; 72; 823-829. [DOI:10.1016/S0015-0282(99)00362-3]
6. Abate A, Brigandi A, Abate FG, Manti F, Unfer V, Perino M. Luteal phase support with 17-hydroxyprogestrone versus unsupported cycles in in vitro fertilization: A comparative randomized study. Gynecol Obstet Invest 1999; 48: 78-80. [DOI:10.1159/000010143]
7. Costabile L, Gerli S, Manna C, Rossetti D, Di Renzo GC, Unfer V. A prospective randomized study comparing intramuscular progesterone and 17-hydroxyprogestrone caproate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 2001; 76: 394-396. [DOI:10.1016/S0015-0282(01)01901-X]
8. Proctor A, Hurst BS, Marshburn PB, Matthews ML. Effect of progesterone supplementation in early pregnancy on the pregnancy outcome after in vitro fertilization. Fertil Steril 2006; 85: 1550-1552. [DOI:10.1016/j.fertnstert.2005.10.060]
9. Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein MD. Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization / embryo transfer in women under age 40: interim analysis of a prospective randomized trial. Fertil Steril 2008; 89: 485-487. [DOI:10.1016/j.fertnstert.2007.03.006]
10. Kahraman S, Karagozoglu SH, Karlikaya G. The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial. Fertil Steril 2010; 94: 761-763. [DOI:10.1016/j.fertnstert.2009.10.004]
11. Abu-Musa A, Usta I, Nassar A, Hajami F, Hannoun A. Effect of 17 alpha-hydroxyprogestrone caproate before embryo transfer on the outcome of in vitro fertilization and embryo transfer: a randomized trial. Fertl Steril 2008; 89: 1098-1102. [DOI:10.1016/j.fertnstert.2007.05.043]
12. Miles RA, Paulson RJ, Lobo RA, Press MF, Dahmoush L, Sauer MV. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril 1994; 62: 485-490. [DOI:10.1016/S0015-0282(16)56935-0]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
